Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review
Guillaume Fond, Marc-Antoine d’Albis, Stéphane Jamain, et al.
Schizophrenia Bulletin (2015) Vol. 41, Iss. 3, pp. 559-573
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

The complement system in schizophrenia: where are we now and what’s next?
Julia Woo, Jennie G. Pouget, Clement C. Zai, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 1, pp. 114-130
Closed Access | Times Cited: 121
A Roadmap for the Development of Applied Computational Psychiatry
Martin P. Paulus, Quentin J. M. Huys, Tiago V. Maia
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2016) Vol. 1, Iss. 5, pp. 386-392
Open Access | Times Cited: 105
Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations
Joana Prata, Susana G. Santos, Maria Inês Almeida, et al.
Journal of Neuroinflammation (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 105
Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship
Daniela Rodrígues-Amorím, Tania Rivera‐Baltanás, Carlos Spuch, et al.
Schizophrenia Research (2017) Vol. 197, pp. 19-33
Closed Access | Times Cited: 105
MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients
Daniella Dwir, Basilio Giangreco, Lijing Xin, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 11, pp. 2889-2904
Open Access | Times Cited: 105
Theranostic Biomarkers for Schizophrenia
Matea Nikolac Perković, Gordana Nedić Erjavec, Dubravka Švob Štrac, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 4, pp. 733-733
Open Access | Times Cited: 99
Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in different stages of schizophrenia
Selçuk Özdin, Ömer Böke
Psychiatry Research (2018) Vol. 271, pp. 131-135
Closed Access | Times Cited: 96
Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset
E. Bulzacka, Laurent Boyer, Franck Schürhoff, et al.
Schizophrenia Bulletin (2016) Vol. 42, Iss. 5, pp. 1290-1302
Open Access | Times Cited: 86
Is It Possible to Predict the Future in First-Episode Psychosis?
Jaana Suvisaari, Outi Mantere, Jaakko Keinänen, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 83
C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
Guillaume Fond, Christophe Lançon, Pascal Auquier, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 76
Assessing and Improving the Quality in Mental Health Services
Lampros Samartzis, Μichael A. Talias
International Journal of Environmental Research and Public Health (2019) Vol. 17, Iss. 1, pp. 249-249
Open Access | Times Cited: 72
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
Emanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 67
Schizophrenia: A review of potential biomarkers
Daniela Rodrígues-Amorím, Tania Rivera‐Baltanás, Marta López, et al.
Journal of Psychiatric Research (2017) Vol. 93, pp. 37-49
Closed Access | Times Cited: 58
Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort
Guillaume Fond, O. Godin, Laurent Boyer, et al.
European Archives of Psychiatry and Clinical Neuroscience (2018) Vol. 269, Iss. 8, pp. 985-992
Closed Access | Times Cited: 57
DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder
Alladi Charanraj Goud, Bruno Étain, Frank Bellivier, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3026-3026
Open Access | Times Cited: 57
Cesarean Section or Natural Childbirth? Cesarean Birth May Damage Your Health
Chen Hong-yan, Dingliang Tan
Frontiers in Psychology (2019) Vol. 10
Open Access | Times Cited: 49
A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach
Mattia Veronese, Barbara Santangelo, Sameer Jauhar, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 6, pp. 1122-1132
Open Access | Times Cited: 49
Peripheral Biomarkers for First-Episode Psychosis—Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia
Nuno Trovão, Joana Prata, Orlando von Doellinger, et al.
Psychiatry Investigation (2019) Vol. 16, Iss. 3, pp. 177-184
Open Access | Times Cited: 44
The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
Melisa Kose, Carmine M. Pariante, Paola Dazzan, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 40
Autoimmune phenotypes in schizophrenia reveal novel treatment targets
Emily G. Severance, Faith Dickerson, Robert H. Yolken
Pharmacology & Therapeutics (2018) Vol. 189, pp. 184-198
Open Access | Times Cited: 41
Emotional stress regulation: The role of relative frontal alpha asymmetry in shaping the stress response
Xinwei Zhang, Petra Bachmann, Thomas M. Schilling, et al.
Biological Psychology (2018) Vol. 138, pp. 231-239
Closed Access | Times Cited: 41
Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studies
Davide Amato, Clare L. Beasley, Margaret Hahn, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 76, pp. 317-335
Open Access | Times Cited: 39
Immune and metabolic alterations in first episode psychosis (FEP) patients
Luisella Bocchio‐Chiavetto, Roberta Zanardini, Sarah Tosato, et al.
Brain Behavior and Immunity (2018) Vol. 70, pp. 315-324
Closed Access | Times Cited: 37
Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort
Guillaume Fond, Noémie Resseguier, Franck Schürhoff, et al.
European Archives of Psychiatry and Clinical Neuroscience (2017) Vol. 268, Iss. 6, pp. 541-553
Closed Access | Times Cited: 35
Predicting major mental illness: ethical and practical considerations
Stephen M. Lawrie, Sue Fletcher‐Watson, Heather C. Whalley, et al.
BJPsych Open (2019) Vol. 5, Iss. 2
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top